92967-9  Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detectionMiddle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detectionMiddle East respiratory syndrome coronavirus RNA: PrThr: Pt: Respiratory.lower: Ord: Non-probe.amp.tar  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Middle East respiratory syndrome coronavirus RNA  PrThr  Pt  Respiratory.lower  Ord  Non-probe.amp.tar
  Long Common Name:  Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
  Short Name:  MERS-CoV RNA Lower Resp Ql NAA+non-probe
  Display Name:  MERS-CoV RNA NAA+non-probe Ql (Lower resp)

PART DEFINITION/DESCRIPTION(S)
  Part: Middle East respiratory syndrome coronavirus
  Middle East Respiratory Syndrome (MERS) is an illness caused by the virus Middle East Respiratory Syndrome Coronovirus (MERS-CoV). The illness was first reported in Saudi Arabia in 2012, but was later found to have originated in Jordan in 2012. MERS has been found in camels leading to speculation that they may be the initial reservoir for the virus. The largest outbreak of MERS that has occurred outside of the Arabian Peninsula was in the Republic of Korea in 2015 and was linked to an individual who had been traveling in the Arabian Peninsula. The virus is probably spread through respiratory secretions from infected individuals though the exact mode of transmission is under investigation. Infection with MERS begins with an incubation period of 5-6 days followed by a severe acute illness that involves fever, shortness of breath and for patients with comorbidities or reduced immunity can lead to pneumonia and kidney failure. The mortality rate of MERS is 3-4 out of 10 people who are infected, though most of the people who die have underlying conditions. In addition, some people experience only cold-like symptoms and others have no symptoms at all. In the United States, most state laboratories are approved to test for MERS-CoV using the real-time reverse transcription–PCR assay developed by the CDC. The assay can be run on respiratory, serum and stool specimens. [CDC: coronavirus/mers]
 
 

BASIC ATTRIBUTES
  Class/Type: MICRO/Lab
  First Released in Version: 2.66
  Last Updated in Version: 2.66
  Order vs. Obs.: Both
  Status: Active

EXAMPLE ANSWER LIST    (LL744-4)  
 
Source: Regenstrief Institute
  SEQ#        Answer        Answer ID    
  1       Detected       LA11882-0  
  2       Not detected       LA11883-8  

MEMBER OF THESE EQUIVALENCE GROUPS
  LG50060-9  Middle East respiratory syndrome coronavirus RNA|PrThr|Sys:ANYResp

PARTS

Part Type    Part No.  Part Name   
Component   LP173752-9  Middle East respiratory syndrome coronavirus RNA   [Middle East respiratory syndrome coronavirus (MERS-CoV) RNA] 
Component   LP173753-7  Middle East respiratory syndrome coronavirus   [Middle East respiratory syndrome coronavirus (MERS-CoV)] 
     Suffix   LP32423-3  RNA 
Property   LP217195-9  PrThr   [Presence or Threshold] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP201886-1  Respiratory.lower   [Lower respiratory specimen] 
Scale   LP7751-3  Ord 
Method   LP208998-7  Non-probe.amp.tar   [Nucleic acid amplification with non-probe detection] 
Fragments for synonyms   LP35082-4  Lower 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Sindrome respiratoria mediorientale da Coronavirus (MERS) , RNA:PrThr:Pt:Sistema respiratorio.inferiore:Ord:Non-sonda.amp.tarSindrome respiratoria mediorientale da Coronavirus (MERS) , RNA:PrThr:Pt:Sistema respiratorio.inferiore:Ord:Non-sonda.amp.tar
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Coronavirus del sindrome respiratorio de Oriente medio RNA:PrThr:Punto temporal:Tracto respiratorio inferior:Ord:Amplificación del objetivo no basado en sondaCoronavirus del sindrome respiratorio de Oriente medio RNA:PrThr:Punto temporal:Tracto respiratorio inferior:Ord:Amplificación del objetivo no basado en sonda

RELATED NAMES
  3 Self-Sustaining Sequence Replication Lower Resp Probe with ampification
  3SR SR MERS-CoV Probe with target amplification
  Amplif MERS-CoV RNA QBR
  Amplification Microbiology QL
  Amplified NAA+non-probe Qual
  Camel flu NAA+probe Qualitative
  Corona virus NAAT Random
  DNA NUCLEIC ACID PROBE NASBA Ribonucleic acid
  DNA probe Nucleic acid sequence based analysis Screen
  HCoV-EMC/2012 Ordinal SDA
  LAT PCR Strand Displacement Amplification
  LCR Point in time TMA
  Ligase chain reaction Polymerase chain reaction Transcription mediated amplification
  Ligation-activated transcription PR  
  Low Probe amp  

CHANGE HISTORY
  Change Type: ADD

INTERNAL FIELDS
  Detail Page Created On: 6/20/2019 9:00:20 AM
  Long Common Name: Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
  Shortname: MERS-CoV RNA Lower Resp Ql NAA+non-probe
  Fully Specified Name: Middle East respiratory syndrome coronavirus RNA: PrThr: Pt: Respiratory.lower: Ord: Non-probe.amp.tar
     
  Component Word Count: 6
  ID: 100547
  Status (Raw): ACTIVE